SCHEMBL2913556

SCHEMBL2913556

CC(C)(C)c1cc(N2C(=O)CCNC2=O)cc(C(=O)Nc2ccc3ncccc3c2)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.46
RAB9A P51151 7/20 0.46
HTT P42858 1/20 0.44
POLB P06746 2/20 0.44
PABPC1 P11940 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
MAT2A P31153 2/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912963 0.84 ALDH1A1 (0.42) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1530825 0.83 AURKB (0.46) NPC1RAB9AHTTPOLBPABPC1
SCHEMBL2913166 0.80 XDH (0.38) NPC1RAB9AHTTMEN1KMT2A
SCHEMBL2908073 0.80 NR1H4 (0.47) MEN1KMT2A
SCHEMBL2910962 0.79 RAB9A (0.39) NPC1RAB9AHTTPOLBMEN1
SCHEMBL2913446 0.79 ALDH1A1 (0.36) NPC1RAB9AHTTPOLBMEN1
SCHEMBL2910190 0.79 GPR27 (0.42) MEN1KMT2A
SCHEMBL2906969 0.79 ALDH1A1 (0.36) NPC1RAB9AHTTPOLBMEN1
SCHEMBL2910683 0.78 ALDH1A1 (0.36) RAB9AMAPTALDH1A1
SCHEMBL2915626 0.78 ITGA4 (0.34) NPC1RAB9AHTTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed